Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice

Oncotarget. 2017 Mar 21;8(12):19947-19967. doi: 10.18632/oncotarget.15256.

Abstract

Understanding functional interactions between DCs and antigens is necessary for achieving an optimal and desired immune response during vaccine development. Here, we identified and characterized protein Rv2299c (heat-shock protein 90 family), which effectively induced DC maturation. The Rv2299c-maturated DCs showed increased expression of surface molecules and production of proinflammatory cytokines. Rv2299c induced these effects by binding to TLR4 and stimulating the downstream MyD88-, MAPK- and NF-κB-dependent signaling pathways. The Rv2299c-maturated DCs also showed an induced Th1 cell response with bactericidal activity and expansion of effector/memory T cells. The Rv2299c-ESAT-6 fused protein had greater immunoreactivity than ESAT-6. Furthermore, boosting BCG with the fused protein significantly reduced hypervirulent Mycobacterium tuberculosis HN878 burdens post-challenge. The pathological study of the lung from the challenged mice assured the efficacy of the fused protein. The fused protein boosting also induced Rv2299c-ESAT-6-specific multifunctional CD4+ T-cell response in the lungs of the challenged mice. Our findings suggest that Rv2299c is an excellent candidate for the rational design of an effective multiantigenic TB vaccine.

Keywords: DC maturation; Toll-like receptor 4; multifunctional T cell; subunit vaccine; tuberculosis.

MeSH terms

  • Animals
  • Antigens, Bacterial / immunology*
  • BCG Vaccine / administration & dosage
  • BCG Vaccine / immunology*
  • Bacterial Proteins / immunology*
  • CD4-Positive T-Lymphocytes / immunology
  • Cell Differentiation
  • Cells, Cultured
  • Cytokines / metabolism
  • Dendritic Cells / immunology*
  • Female
  • Immunologic Memory / immunology
  • Mice
  • Mice, Inbred C57BL
  • Mycobacterium tuberculosis / immunology*
  • Mycobacterium tuberculosis / pathogenicity
  • Recombinant Fusion Proteins / immunology
  • Th1 Cells / immunology
  • Tuberculosis, Pulmonary / immunology
  • Tuberculosis, Pulmonary / microbiology
  • Tuberculosis, Pulmonary / prevention & control*
  • Vaccines, Subunit / therapeutic use*

Substances

  • Antigens, Bacterial
  • BCG Vaccine
  • Bacterial Proteins
  • Cytokines
  • ESAT-6 protein, Mycobacterium tuberculosis
  • Recombinant Fusion Proteins
  • Vaccines, Subunit